Market Cap : 482.03 M | Enterprise Value : 965.38 M | PE Ratio : At Loss | PB Ratio : 0.63 |
---|
NAS:ZIMV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ZIMV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
ZimVie's revenue for the three months ended in Jun. 2022 was $234.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Jun. 2022 was $971.3 Mil. ZimVie's Revenue per Share for the three months ended in Jun. 2022 was $9.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $37.24.
Warning Sign:
ZimVie Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of ZimVie was 23.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 4 years, ZimVie's highest 3-Year average Revenue per Share Growth Rate was -2.60% per year. The lowest was -2.60% per year. And the median was -2.60% per year.
The historical data trend for ZimVie's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ZimVie's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's Revenue distribution charts can be found below:
* The bar in red indicates where ZimVie's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $971.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Thank you for viewing the detailed overview of ZimVie's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Crawford Sally | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Kuntz Richard | director | MEDTRONIC, INC. 710 MEDTRONIC PWKY MS LC 310 MINNEAPOLIS MN 55432 |
Asar Vinit K | director | 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 |
Matusinec Karen | director | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
King David P | director | PRIVIA HEALTH GROUP, INC. 950 N. GLEBE RD., SUITE 700 ARLINGTON VA 22203 |
Zimmer Biomet Holdings, Inc. | 10 percent owner | 345 EAST MAIN STREET WARSAW IN 46580 |
Whitney Rebecca Ann | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Harmon David John | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Jamali Vafa | director, officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kanaglekar Indraneel | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kidwell Heather | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Schneider Sandra | officer: Chief Accounting Officer | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Heppenstall Richard | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
From GuruFocus
Other Sources